Insider filing · JAZZ
Robert Iannone
EVP, Global Head of R&D & CMO
profile →
Jazz Pharmaceuticals plc
JAZZ · Healthcare · 46 filings in 24 months
ticker →
Robert Iannone sold $1.2M of Jazz Pharmaceuticals (JAZZ)
Executed Nov 17 2025, disclosed Nov 19 2025, 2 days later.
Value, as filed
$1.2M
7,159 sh × $168.26
Executed
Nov 17 2025
the trade date, as filed
Disclosed
Nov 19 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RIRobert Iannone (EVP, Global Head of R&D & CMO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Jazz Pharmaceuticals plc (JAZZ). The largest single filing was $19.1M of JAZZ (76,621 sh across 5 lots, as filed), executed Aug 27.
The name
JAZZHealthcare · Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Robert Iannone in JAZZ
JAZZSALE
Jazz Pharmaceuticals plc
$19.1M76,621 sh across 5 lots
Exec Aug 27
Filed Aug 31 · 6:45 PM ET JAZZSALE Jazz Pharmaceuticals plc $333K
2,403 sh × $138.41
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $981K
7,080 sh across 2 lots
Exec Mar 7 2025
Filed Mar 7 2025 · 5:30 PM ET